Establishment of Nation-Wide Class Rejected in Securities Case

Nutter McClennen & Fish LLP
Contact
In Jackie 888, Inc. v. Tokai Pharmaceuticals, Inc., Jackie 888 sued Tokai on behalf of itself and a putative class of individuals who had purchased Tokai stock, alleging Tokai made misleading statements in an IPO registration statement and prospectus. Jackie 888 moved for class certification.

The class-certification motion, Judge Sanders wrote, raised this question: “[Can] a Massachusetts state court … consistent with Due Process, certify a nationwide class and thus exercise personal jurisdiction over out-of-state plaintiffs where Massachusetts Rule 23 does not contain a provision allowing these absent class members to ‘opt out’”?

The answer, Judge Sanders ruled, is no.

Citing Moelis v. Berkshire Life Ins. Co., 451 Mass. 483 (2008), Judge Sanders pointed out that where a plaintiff cannot procedurally opt out of a class, a Massachusetts court can assert personal jurisdiction over absent class plaintiffs only if they had “minimum contacts” with the Commonwealth. Turning to the facts, Judge Sanders found that the absent class plaintiffs’ only contact with Massachusetts—the purchase of stock (through agents in other states) issued by a Delaware corporation headquartered in Massachusetts—did not meet the minimum-contacts test.

Judge Sanders rejected Jackie 888’s argument that absent class members’ stock purchases themselves constituted minimum contacts with the Commonwealth. “This argument,” Judge Sanders wrote, “misses the point in that it focuses on the defendants’ rather than the plaintiffs’ contacts with the forum state.”

We previously blogged about a similar decision from Judge Kaplan, who stayed a securities litigation filed in the BLS in favor of a parallel case filed in federal court. We blogged about that case—Lowinger v. Solid Biosciences Inc.here.

The Business Litigation Session of the Massachusetts Superior Court

Docket Number: 2018-1591-BLS 2

Case Name: Jackie 888, Inc., individually and behalf of other similarly situated v. Tokai Pharmaceuticals, Inc., et al.

Date of Decision: November 25, 2019

Judge: Janet L. Sanders

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Nutter McClennen & Fish LLP | Attorney Advertising

Written by:

Nutter McClennen & Fish LLP
Contact
more
less

Nutter McClennen & Fish LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide